LicianPro

Ensysce Biosciences, Inc. ·

ENSC 8-K 2026-09-29

Ensysce Biosciences, Inc. (ENSC) 8-K dated 2026-09-29 — accession 0001493152-26-044802.

Ensysce Biosciences, Inc. (ENSC) is a biotechnology company listed on US.

Ensysce Biosciences, Inc. filed a 8-K on 2026-09-29. Accession 0001493152-26-044802.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M.

Not investment advice. The ENSC SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr